This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Problems related to care-provider dependency
Z21_PROBL_RELATED_CARE__DEPENDENCY
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
298 |
4. Check minimum number of eventsNone |
298 |
5. Include endpointsNone |
298 |
6. Filter based on genotype QC (FinnGen only) |
293 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z7
Similar endpoints
↥List of similar endpoints to
Problems related to care-provider dependency
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services in other circumstances, wide
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 293 | 123 | 170 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.08 |
| Median age at first event (years) | 75.61 | 75.19 | 75.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 298
- Matched controls
- 2980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
+∞
133.7
118
*
Z74.2
ICD-10 Finland
Need for assistance at home and no other household member able to render care
+∞
70.7
65
*
Z74.1
ICD-10 Finland
Need for assistance with personal care
+∞
54.9
51
*
Z74.8
ICD-10 Finland
Other problems related to care-provider dependency
+∞
46.0
43
*
Z75.5
ICD-10 Finland
Holiday relief care
+∞
43.8
41
*
N03AG01
ATC
valproic acid; systemic, rectal
10.2
39.5
48
55
A29
ICPC
General symptom/complaint other
4.6
28.1
84
236
N05AX08
ATC
risperidone; systemic
4.8
27.1
74
193
N05AH03
ATC
olanzapine; systemic
8.3
26.5
37
50
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.8
26.1
69
175
A28
ICPC
Limited function/disability NOS
3.7
25.9
116
433
SPAT1229
SPAT
Assessment of need for aid
5.2
23.9
56
128
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.8
23.3
91
307
R51
NOMESCO Finland
Aids services
+∞
23.2
22
*
Z74.9
ICD-10 Finland
Problem related to care-provider dependency, unspecified
+∞
23.2
22
*
A06AD11
ATC
lactulose; oral
3.5
21.8
105
404
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.3
20.5
37
66
F03
ICD-10 Finland
Unspecified dementia
4.6
20.3
55
141
N02AA05
ATC
oxycodone; systemic
3.3
19.5
96
371
N05AH04
ATC
quetiapine; oral
3.7
19.2
75
250
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
18.4
143
713
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
18.1
56
158
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.9
17.8
34
64
WZC00, ,
SPAT
4.7
17.7
45
109
SPAT1262
SPAT
Handing over of treatment supplies
3.4
17.7
80
292
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.1
17.2
53
149
WX704
NOMESCO Finland
Intubation
5.1
16.6
37
80
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
16.3
81
312
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.1
15.5
82
326
N05BA04
ATC
oxazepam; oral
2.8
15.3
106
489
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.5
15.1
61
206
N05AA02
ATC
levomepromazine; systemic
6.1
14.4
26
46
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.7
14.0
34
79
CA1ME
NOMESCO Finland
Ultrasound oculometry
25.2
14.0
19
8
N05BA06
ATC
lorazepam; systemic, sublingual
4.8
13.7
33
76
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.0
13.6
25
45
K90
ICPC
Stroke/cerebrovascular accident
6.1
13.4
24
42
SPAT1249
SPAT
Treatment-related counselling outside office
2.5
13.3
120
624
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.9
13.1
30
66
N05AD01
ATC
haloperidol; systemic
5.4
12.7
26
52
N06AB04
ATC
citalopram; systemic
2.7
12.3
84
379
N03AE01
ATC
clonazepam; systemic
4.9
12.2
28
62
N03AF01
ATC
carbamazepine; oral, rectal
4.1
11.8
34
90
WYA20
NOMESCO Finland
Home visit
5.9
11.8
22
40
P29
ICPC
Psychological sympt/compl other
5.6
11.7
23
44
WW200, ,
SPAT
2.7
11.2
70
300
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
12.6
11.0
19
16
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.6
11.0
38
115
R53
ICD-10 Finland
Malaise and fatigue
2.4
11.0
96
485
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.0
10.9
24
51
N05BA01
ATC
diazepam; systemic, rectal
2.9
10.7
58
230
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.0
10.7
22
26
SPAT1255
SPAT
Intravenous administration of medicine
3.8
10.7
34
97
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
10.7
96
490
J01MA02
ATC
ciprofloxacin; systemic
2.3
10.6
143
866
N30.0
ICD-10 Finland
Acute cystitis
2.9
10.6
58
232
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.2
10.4
19
18
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
10.4
130
762
WX892
NOMESCO Finland
Monitored bed care
3.6
10.2
35
105
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
10.2
34
100
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.5
10.1
37
116
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
10.1
70
316
J01EA01
ATC
trimethoprim; systemic
2.3
9.9
105
573
N03AX12
ATC
[U] gabapentin; oral
2.8
9.8
57
235
A60
ICPC
General and Unspecified, Result test/procedure
4.4
9.6
25
61
N05AX12
ATC
aripiprazole; systemic
15.7
9.6
15
10
UKC02
NOMESCO Finland
Cystoscopy
2.4
9.4
76
367
C03CA01
ATC
furosemide; systemic
2.1
9.4
158
1031
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
9.3
58
247
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
4.8
9.2
21
46
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
9.1
89
466
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
9.0
65
297
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.9
8.6
45
175
WZC30, ,
SPAT
4.2
8.5
23
58
N03AX14
ATC
levetiracetam; systemic
8.3
8.5
18
23
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
9.9
8.4
16
17
Z75.0
ICD-10 Finland
Medical services not available in home
+∞
8.4
8
*
Z74.3
ICD-10 Finland
Need for continuous supervision
+∞
8.4
8
*
WX725
NOMESCO Finland
Noninvasive ventilation
4.1
8.1
23
60
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
4.3
7.9
21
52
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.7
7.9
26
76
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.8
7.7
42
166
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
19.0
7.7
11
6
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.6
7.6
25
73
S97
ICPC
Chronic ulcer skin
3.2
7.5
31
105
Z75.8
ICD-10 Finland
Other problems related to medical facilities and other health care
+∞
7.3
7
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.5
7.3
48
209
SPAT1193
SPAT
Pap smear
4.7
7.3
17
38
K59.09
ICD-10 Finland
Constipation, unspecified
3.0
7.1
32
114
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
3.3
7.1
27
87
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
6.6
7.0
17
27
SPAT1252
SPAT
Overall medication plan or its review
3.0
6.9
31
110
WX882
NOMESCO Finland
High dependency care
6.4
6.9
17
28
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
17.2
6.8
10
6
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
41.0
6.8
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
6.7
21
59
NFQ20
NOMESCO Finland
Amputation of femur
8.1
6.7
14
18
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
6.7
44
192
N06DX01
ATC
memantine; oral
2.4
6.6
51
239
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
7.1
6.6
15
22
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.4
6.6
16
26
N05CD07
ATC
temazepam; oral
2.2
6.4
61
312
Z51.5
ICD-10 Finland
Palliative care
2.7
6.4
36
145
N06AB06
ATC
sertraline; oral
2.9
6.3
31
116
SPAT1285
SPAT
Provision of consultation response
3.8
6.3
19
52
ZYC01, ,
SPAT
3.0
6.3
28
99
M03BX01
ATC
baclofen; systemic
7.3
6.3
14
20
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
6.3
58
294
N03AX09
ATC
lamotrigine; oral
6.5
6.2
15
24
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
6.2
36
147
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
6.1
85
501
R50.9
ICD-10 Finland
Fever, unspecified
2.3
6.0
48
228
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
71
156
5.66
32.10
6.5
6.3
25.41
24.08
mmol/l
1.87
71
144
83
210
5.09
31.91
6.1
7.1
121.84
120.02
g/l
0.36
83
201
125
454
4.02
29.62
9.3
4.8
1.02
1.02
kg/l
0.01
79
62
132
509
3.86
28.47
8.5
4.6
0.00
0.00
estimate
-0.00
11
132
39
54
8.16
27.39
2.4
1.8
—
—
—
0
0
85
272
3.97
23.48
7.0
6.1
11.46
11.43
kpa
0.02
85
252
85
272
3.97
23.48
7.0
6.1
5.12
5.01
kpa
0.50
85
252
83
274
3.81
21.78
7.2
6.1
2.40
0.99
mmol/l
4.11
74
211
43
91
5.35
19.86
7.8
4.9
2.00
1.57
%
2.36
43
81
138
724
2.69
15.48
9.3
4.6
—
—
—
0
0
160
920
2.60
14.65
8.6
4.2
0.00
0.00
estimate
-0.00
13
130
26
25
11.28
14.04
2.0
1.8
—
—
—
0
0
157
913
2.52
13.78
8.7
4.3
0.00
0.01
estimate
0.50
13
154
157
914
2.52
13.73
10.2
5.6
0.00
0.00
estimate
-0.00
11
136
49
153
3.64
13.58
2.3
1.6
—
—
—
0
0
29
68
4.62
11.77
1.6
1.2
—
—
—
0
0
87
472
2.19
8.09
2.1
1.8
416.23
424.08
pmol/l
0.11
82
384
12
12
10.36
6.59
2.5
1.1
—
—
—
0
0
129
859
1.88
6.52
5.8
4.4
58.67
50.47
ng/l
0.15
110
643
21
61
3.63
6.41
12.7
2.9
25.59
24.76
mmol/l
0.31
21
61
52
259
2.22
5.83
1.8
1.7
—
—
—
0
0
143
1009
1.80
5.81
10.4
6.5
1.21
1.21
mmol/l
0.28
132
824
51
261
2.15
5.34
2.0
1.8
—
—
—
0
0
15
40
3.90
5.16
1.5
1.4
—
—
—
0
0
31
133
2.49
4.86
1.5
1.5
—
—
—
0
0
80
496
1.84
4.83
2.0
1.8
1146.44
1127.65
nmol/l
0.09
67
365
62
366
1.88
4.33
2.2
1.8
—
—
—
0
0
7
6
11.90
4.29
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
6
11.90
4.29
1.0
1.0
—
—
—
0
0
70
444
1.75
3.85
5.1
3.8
68.00
221.31
ng/l
1.88
59
390
122
897
1.61
3.82
6.5
4.7
33.57
34.50
g/l
1.00
114
817
14
45
3.22
3.70
1.5
1.5
228.22
363.84
ug/g
—
9
23
88
602
1.66
3.65
2.4
2.2
2.65
3.27
mg/l
1.40
81
506
6
6
10.17
3.51
34.5
4.0
1.16
1.18
mmol/l
—
6
6
102
738
1.58
3.33
5.0
3.4
—
—
—
0
0
11
34
3.32
2.75
1.6
1.5
18.11
22.49
iu/l
0.24
11
28
110
851
1.46
2.50
3.0
2.5
—
—
—
0
0
9
26
3.54
2.50
1.6
1.3
—
—
—
0
0
8
21
3.88
2.48
2.1
2.3
—
—
—
0
0
18
85
2.19
2.34
2.8
2.7
—
—
—
0
0
6
13
4.69
2.28
1.0
1.0
—
—
—
0
0
8
25
3.26
2.11
2.8
2.6
—
—
—
0
0
6
15
4.06
2.05
1.3
1.0
—
—
—
0
0
6
15
4.06
2.05
2.3
3.9
—
—
—
0
0
6
15
4.06
2.05
1.5
1.5
—
—
—
0
0
6
15
4.06
2.05
1.5
1.5
—
—
—
0
0
12
51
2.41
1.97
1.4
1.5
7.30
0.03
iu/ml
—
6
11
10
39
2.62
1.96
1.6
1.3
—
—
—
0
0
5
11
4.60
1.95
1.2
1.0
—
—
—
0
0
16
78
2.11
1.94
4.8
2.9
—
—
—
0
0
128
1056
1.37
1.92
26.5
18.9
1.39
1.38
inr
0.06
58
253
6
17
3.58
1.84
1.3
1.0
—
—
—
0
0
160
1819
0.74
1.80
4.9
5.1
2.42
2.56
mmol/l
1.19
152
1607
153
1743
0.75
1.69
4.5
4.5
1.31
1.42
mmol/l
2.80
144
1532
23
137
1.74
1.60
14.3
3.7
3.87
2.35
mmol/l
1.02
14
105
156
1759
0.76
1.52
4.6
4.5
4.17
4.42
mmol/l
2.22
146
1566
30
443
0.64
1.51
2.2
3.0
0.84
0.81
ug/l
0.09
24
300
149
1681
0.77
1.41
4.2
4.1
1.37
1.26
mmol/l
1.08
141
1469
125
1069
1.29
1.36
14.0
8.5
5.18
4.39
e9/l
1.78
113
929
172
1556
1.25
1.10
43.8
19.8
14.61
15.34
%
2.48
172
1516
205
1895
1.26
1.07
34.0
16.3
32.49
27.57
mg/l
1.32
195
1531
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
76
1.74
1.00
1.5
2.8
0.56
0.35
u/ml
—
7
39
163
1782
0.81
1.00
4.6
4.7
6.30
6.06
mmol/l
1.03
155
1553
108
936
1.24
1.00
2.6
2.5
—
—
—
0
0
9
49
1.86
0.99
1.6
1.4
—
—
—
0
0
9
49
1.86
0.99
1.6
1.4
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
0
29
0.00
0.98
0.0
2.1
—
32.33
—
0
6
26
186
1.44
0.91
7.5
7.2
1.48
1.40
mmol/l
0.14
26
180
6
29
2.09
0.90
1.8
1.8
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
23
168
1.40
0.74
1.6
1.4
—
—
—
0
0
7
38
1.86
0.74
1.6
1.9
—
—
—
0
0
5
26
1.94
0.71
2.8
2.6
16.40
43.73
u/ml
—
5
26
41
331
1.28
0.70
3.5
2.4
2.41
2.23
g/l
0.97
41
293
7
42
1.68
0.69
1.4
1.5
—
—
—
0
0
27
207
1.33
0.66
3.9
5.6
1.51
1.67
mmol/l
0.07
21
152
23
177
1.32
0.56
3.3
4.6
4.33
4.31
kpa
0.02
18
166
5
90
0.55
0.56
13.0
4.0
24.26
25.58
mmol/l
—
5
85
180
1698
1.15
0.55
33.4
15.4
66.43
73.53
ml/min/173m2
2.14
127
1373
69
608
1.18
0.53
3.4
3.5
20.16
10.45
mg/mmol
0.89
43
381
6
96
0.62
0.53
2.0
2.1
—
—
—
0
0
30
244
1.26
0.50
2.5
4.1
5.30
52.90
ug/l
0.88
22
209
38
450
0.82
0.50
2.3
2.2
—
—
—
0
0
150
1405
1.14
0.49
5.1
3.8
18.24
14.62
mm/h
1.57
144
1250
37
312
1.21
0.46
3.9
2.5
20.15
20.81
%
0.10
24
258
5
31
1.62
0.43
1.0
2.0
—
—
—
0
0
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
56
496
1.16
0.41
2.7
2.8
9425.14
12659.05
umol/l
0.13
51
415
51
577
0.86
0.41
6.2
3.4
0.76
0.49
e6/l
0.45
41
453
8
59
1.37
0.41
2.1
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
8
60
1.34
0.40
1.4
1.7
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
18.32
31.94
u/l
—
5
28
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
8
61
1.32
0.40
1.4
1.2
—
—
—
0
0
8
61
1.32
0.40
1.4
1.2
—
—
—
0
0
5
35
1.44
0.39
1.8
1.3
—
2.05
—
0
6
143
1351
1.11
0.38
4.5
3.5
14.87
15.11
pmol/l
0.53
134
1161
10
132
0.75
0.33
3.3
1.6
—
—
—
0
0
19
157
1.22
0.30
3.8
3.8
43.50
54.86
ml/min/173m2
—
8
74
38
340
1.13
0.26
1.5
1.2
4.28
2.11
u/ml
—
8
86
68
631
1.10
0.25
4.9
4.9
21.49
21.67
%
0.04
36
322
11
87
1.27
0.24
1.5
1.1
149.98
126.10
iu/ml
—
6
36
116
1106
1.08
0.24
3.6
3.1
60.40
52.74
u/l
0.36
107
1008
5
39
1.29
0.23
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
0
11
0.00
0.21
0.0
5.4
—
229.45
—
0
11
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
174.57
—
0
12
0
12
0.00
0.21
0.0
2.5
—
13.89
—
0
12
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
94
893
1.08
0.21
2.1
2.1
87.48
89.13
pmol/l
0.15
61
463
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
14
120
1.17
0.16
11.4
7.8
25.07
24.28
mmol/l
0.49
14
112
6
77
0.77
0.16
3.8
1.6
—
—
—
0
0
38
353
1.09
0.15
4.3
2.9
1.05
1.38
e6/l
0.51
20
218
7
86
0.81
0.15
1.4
1.9
—
—
—
0
0
7
87
0.80
0.14
3.9
1.7
—
—
—
0
0
34
318
1.08
0.11
4.9
3.1
1.19
1.76
e6/l
0.33
17
187
5
44
1.14
0.10
4.4
1.8
—
—
—
0
0
28
262
1.08
0.09
1.3
1.2
11.68
38.23
iu/ml
2.62
12
77
5
48
1.04
0.09
5.2
1.4
—
—
—
0
0
24
224
1.08
0.08
6.4
3.6
—
—
—
0
0
7
64
1.10
0.08
1.0
1.0
—
—
—
0
0
42
404
1.05
0.06
1.5
1.8
1.35
1.40
mg/l
0.06
31
323
13
140
0.93
0.04
16.8
3.9
1.17
1.22
mmol/l
1.38
13
120
23
219
1.05
0.04
1.3
1.5
—
—
—
0
0
28
269
1.05
0.04
12.0
9.4
—
—
—
0
0
208
2068
1.02
0.03
46.6
23.9
37.72
39.10
%
1.40
129
1880
208
2069
1.02
0.02
46.5
23.8
126.35
132.70
g/l
7.09
199
2012
208
2069
1.02
0.02
46.0
23.7
4.25
4.40
e12/l
3.83
200
1987
168
1691
0.99
0.02
5.6
4.3
2.01
2.03
mu/l
0.05
159
1459
22
227
0.97
0.01
1.6
1.2
0.94
10.75
u/ml
—
5
69
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
90.78
—
0
9
0
5
0.00
-0.00
0.0
5.4
—
7.96
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
66.20
—
0
5
8
82
0.97
-0.00
1.4
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PROBL_RELATED_CARE__DEPENDENCY – Problems related to care-provider dependency
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).